Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05889013 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Utility of PCD Diagnostics to Improve Clinical Care

Study acronym: PCD
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Lead sponsor: Connecticut Children's Medical Center to Connecticut Children's Medical Center
    • Eligibility criteria expanded, about 15 words
  2. Primary completion date: Jun 2025 to Dec 2027
    • Study completion date: Dec 2025 to Dec 2028
    • Site contact updated
    v5
  3. Primary completion date: Jun 2024 to Jun 2025
    • Study completion date: Jun 2024 to Dec 2025
    • Start date: Sep 27, 2023 to Oct 17, 2023
    v4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Oct 2023 to Sep 27, 2023
    v3
  5. Phase: Not applicable to Not specified
    • Start date: Jun 2023 to Oct 2023
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This cross-sectional and longitudinal observational study is to gather data on the utility of tests that are used to make a diagnosis of primary ciliary dyskinesia (PCD). There is new testing available, called nasal nitric oxide testing, that non-invasively measures nitric oxide levels in the sinus cavity. Individuals with PCD characteristically have low levels, but this testing does not have extensive data from everyday clinical practice. The objective of this proposal is to improve the diagnostic approach to children and adults with clinical concerns for primary ciliary dyskinesia (PCD).
Trial Details
NCT Number NCT05889013
Lead Sponsor Connecticut Children's Medical Center
Collaborators: UConn Health
Conditions
(from sponsor)		 Primary Ciliary Dyskinesia
Related terms Ciliary Motility Disorders
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov